The South Africa embolotherapy market is segmented on the basis of product, disease indication, procedure, end user, and country. The report offers insights and in-depth analysis of the market, emphasizing various parameters such as market trends and opportunities, market dynamics, and competitive landscape analysis of leading market players across South Africa. It also includes the impact analysis of COVID–19 pandemic across the country.
Market Insights
Increasing Incidence of Hypertension, Obesity, Smoking, and Alcoholism
Hypertension, smoking, alcoholism, and obesity are associated with developing brain aneurysms. South Africa has the highest prevalence of hypertension; however, the level of awareness and control of the disease is low among communities. According to WHO data, ~27.4% of men and 26.1% of women in South Africa have hypertension, and the prevalence of hypertension was reported to be 60% in 2019. Moreover, obesity is a public health issue in South Africa, and 31% of men and 68% of women in South Africa are obese. In addition, the country is among the world's top five countries with the highest consumption of absolute alcohol per drinker per year. According to WHO, South Africa is affected as 1 in 10 deaths are associated with alcohol use, and approximately half of men and one-fifth of women consume alcohol in South Africa.
Kidney cancer is becoming more common in people of all ages and races, and hypertension, obesity, and smoking are all risk factors for kidney cancer. Obesity is associated with high blood pressure, dyslipidemia, diabetes, and higher fibrinogen levels, which also increase the risk of cardiovascular diseases (CVD). Thus, the increasing prevalence of such diseases fuels the demand for embolotherapy.
Bariatric embolization is a new endovascular technique to cure patients with obesity. Bariatric embolization carries embolic microspheres into the gastric arteries to induce localized ischemia and has modified appetite hormones, leading to reduced weight. Thus, the increasing prevalence of hypertension, smoking, alcoholism, and obesity propels the growth of the South Africa embolotherapy market.
Product-Based Insights
Based on product, the South Africa embolotherapy market is bifurcated into embolic agents and support devices. The embolic agents segment held a larger market share in 2021 and is anticipated to register a higher CAGR in the market during the forecast period. Embolic agents apply mechanical occlusion to block blood flow in one or more blood vessels or abnormal vascular areas. Various embolic agents are placed by using certain ways, such as through catheters into the blood vessels, to inhibit blood flow to a specific area. Embolizing agents such as embolic microsphere restrict the vascular supply of tumors and can be loaded with chemotherapeutic medicines that elute and diffuse into the tissue.
Moreover, in interventional radiology, embolization is a common procedure, and the increasing use of embolic agents in various interventional radiology procedures and advancements in such agents, such as calibrated microspheres for bland embolization and drug-eluting microspheres for treating primary or secondary liver disease are the reasons for the growth of this segment. Furthermore, the embolic agents segment is sub-segmented into microspheres, embolic coil, liquid embolic agents, embolic plug systems, detachable balloons, and others.
Based on disease indication, the South Africa embolotherapy market is segmented into cancer, peripheral vascular disease, neurological diseases, urological & nephrological disorders, gastrointestinal disorders, and others. The cancer segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
Embolization is used to treat cancers such as neuroendocrine tumors, renal cell carcinoma, and hepatocellular carcinoma. The goal of embolization in cancer treatment is to remove the tumor, which cannot be removed surgically due to its deep location within the body. Embolization can also stop fatal bleeding caused by a tumor, and the choice of embolization agents depends on the indication. Some common embolization agents used for treating tumors are metal coils, PVA particles, and soluble gelatin sponge. Thus, embolotherapy is rapidly becoming a preferred treatment for cancer as it cuts the tumor from the blood supply, essentially starving it of nutrients. The procedure has a high success rate and less post-operative complication rate.
Moreover, rising cancer and hepatocellular cancer incidences are the key factors fueling the demand for embolotherapy devices for cancer disease indication during the forecast period. Cancer is the fifth leading cause of death in Africa. The prevalence of cancer has been rising continuously over the last few decades due to a combination of environmental and lifestyle factors and variations in screening and diagnosis. According to Ascopost, an estimated 110,000 new cancer cases were diagnosed in South Africa in 2020, with more than 56,000 cancer-related deaths.
Procedure-Based Insights
Based on procedure, the South Africa embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization (TARE)/selective internal radiation therapy (SIRT), and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. Transcatheter arterial embolization (TAE) is a procedure in which the blood supply to a tumor or an abnormal tissue area is blocked. During TAE procedure, a small incision is made in the inner thigh, and a catheter is inserted and guided into an artery near the tumor. Once the catheter is in place, small particles made of sponges or beads are injected into the artery, blocking the artery and stopping the blood flow to the tumor. Transarterial embolization is used to treat some types of liver cancer, kidney cancer, neuroendocrine tumors, uterine fibroids, aneurysms, and other conditions. Moreover, TAE is effective and well-tolerated in patients with ruptured hepatocellular carcinoma (HCC). This procedure is expected to be the fastest-growing category during the forecast period owing to the rising preference for minimally invasive procedures by the elderly and the growing prevalence of chronic diseases.
End User-Based Insights
Based on end user, the South Africa embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.
Companies commonly adopt inorganic strategies such as mergers and acquisitions to meet changing customer demand and maintain their brand name worldwide. Players operating in the South Africa embolotherapy market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide.
In March 2022, Guerbet expanded its portfolio with microcatheters and guidewires for interventional imaging and embolization.
In July 2021, Terumo introduced a new AZUR Vascular Plug and PG Pro Peripheral Microcatheter Embolization System.
Company Profiles